1. Defensive Measures Available to a Target Board
Boards typically deploy a combination of structural, financial, and procedural defenses. The most common include poison pills, crown jewel defenses, white knights, and golden parachutes. Each mechanism operates within a specific legal framework and carries different shareholder and market implications.
What Is a Poison Pill and How Does It Work in New York Corporate Practice?
A poison pill is a shareholder rights plan that dilutes the bidder's stake if a threshold ownership level is crossed without board approval. The plan grants existing shareholders the right to purchase additional shares at a discount, which becomes exercisable upon a triggering event, typically crossing 15 to 20 percent ownership. New York courts, including the Delaware Court of Chancery, which applies to many New York corporations chartered in Delaware, have upheld poison pills as a valid defensive tactic when the board demonstrates that the pill was adopted in response to a genuine threat and was not preclusive or coercive. The practical significance lies in the timing and documentation of the board's decision: a pill adopted after a bidder has already announced its intentions may face less judicial scrutiny than one adopted in advance, because courts examine whether the board had time to gather information and evaluate alternatives before acting.
Can a Board Deploy a Crown Jewel Defense or Seek a White Knight?
Yes, a crown jewel defense involves selling or agreeing to sell the corporation's most valuable assets if the hostile bidder succeeds, making the target less attractive. A white knight is a friendly third party that the board recruits to make a competing offer. Both tactics are legal, but they require careful board process. The board must demonstrate that it explored the crown jewel sale or white knight alternative as part of a deliberate evaluation of the bidder's offer and the corporation's strategic options. Courts scrutinize whether the board was genuinely shopping for alternatives or simply using the tactic to entrench management. The distinction matters because entrenchment violates the business judgment rule, whereas a good-faith search for a superior proposal does not.
2. Role of Shareholder Rights in a Hostile Takeover
Shareholders retain the ultimate power to accept or reject a tender offer and to vote on any merger or acquisition proposal. The board's role is to evaluate the offer and communicate its recommendation, not to prevent shareholders from deciding. This tension creates the legal and practical core of hostile takeover defense.
Do Shareholders Have the Right to Vote on a Hostile Takeover?
Shareholders must vote on any merger or acquisition that is consummated through a formal merger agreement. A tender offer that does not trigger a merger vote initially may later require shareholder approval depending on the bidder's intentions and the corporation's charter. Under New York law and Delaware law, shareholders cannot be stripped of their voting rights on a fundamental transaction. However, the board can influence the timing and terms of a shareholder vote through defensive tactics. For example, a staggered board or a supermajority voting requirement can delay a vote or raise the threshold for approval, giving the board time to solicit a superior proposal or allowing shareholders to reconsider the bidder's offer as additional information emerges.
What Happens If the Board Refuses to Engage with the Bidder?
A board that refuses to negotiate or communicate with a hostile bidder faces legal risk if shareholders later determine that the board failed to maximize shareholder value. Courts have held that boards cannot simply ignore a credible offer; instead, they must engage in a process that allows them to evaluate the bidder's intentions, assess whether a superior proposal is available, and communicate transparently with shareholders. In practice, even a board that opposes a bid typically enters into confidentiality and standstill agreements with the bidder to obtain financial information and assess the offer's seriousness. Refusal to engage may be viewed as a failure of process, particularly if the bidder's offer is ultimately accepted by shareholders despite the board's opposition.
3. How Fiduciary Duties Shape Defensive Tactics
Directors owe fiduciary duties of care and loyalty to the corporation and its shareholders. In the context of a hostile takeover, these duties require the board to act on an informed basis, avoid conflicts of interest, and prioritize shareholder welfare over management entrenchment. Courts apply heightened scrutiny to defensive measures, examining whether they are proportional to the threat posed by the bidder and whether the board had adequate information when deciding to deploy them.
What Is the Business Judgment Rule and How Does It Apply to Takeover Defenses?
The business judgment rule presumes that directors acted in good faith, on an informed basis, and in a manner they reasonably believed to be in the corporation's best interest. To rebut this presumption, a shareholder plaintiff must demonstrate that the board lacked information, acted in bad faith, or that the defensive measure was so disproportionate to the threat that no reasonable director would adopt it. From a practitioner's perspective, the board's documentation of its decision-making process is critical: meeting minutes, financial advisor opinions, and written board resolutions that explain the rationale for each defensive tactic significantly improve the likelihood that a court will uphold the board's actions under the business judgment rule. Conversely, a board that acts hastily or without adequate process faces a shifted burden of proof, requiring directors to affirmatively demonstrate that the defense was reasonable.
What Fiduciary Duties Arise When a Board Engages with a Hostile Bidder?
Once a board enters into negotiations with a hostile bidder, it must continue to act fairly toward all potential bidders and avoid favoring one bidder over another absent a legitimate business reason. This duty includes an obligation to disclose material information to shareholders and to avoid using confidential information obtained from one bidder to benefit a competing bidder. In New York courts and Delaware courts, breaches of this duty have resulted in injunctions blocking mergers and awards of damages to shareholders. The practical implication is that boards must maintain careful records of all communications with bidders, financial advisors, and legal counsel, and must document the rationale for any decision to favor one bidder or to terminate discussions with another.
4. Strategic Considerations to Guide the Board'S Response
Boards must balance competing pressures: the need to maximize shareholder value, the risk of litigation, market perception, and operational continuity. The choice of defensive tactic depends on the corporation's circumstances and the board's assessment of the bidder's credibility and intentions.
| Defensive Tactic | Legal Status | Key Consideration |
| Poison Pill | Generally upheld if adopted in response to a threat | Timing and board process are critical; pre-bid pills face greater scrutiny |
| Crown Jewel Defense | Permitted if part of a good-faith evaluation | Risk of entrenchment if used to block all bids |
| White Knight | Permitted if process is fair to all bidders | Requires transparent auction process to avoid favoritism claims |
| Staggered Board | Generally upheld in Delaware and New York | Delays bidder control but does not prevent eventual acquisition |
| Golden Parachutes | Permitted if approved by shareholders or board | Disclosure and shareholder vote enhance enforceability |
The board should ensure that any defensive measure is adopted only after a full evaluation of the bidder's offer, consultation with financial and legal advisors, and consideration of shareholder interests. Documentation of this process is essential for defending against later shareholder litigation. Additionally, boards should consider whether the defensive tactic is preclusive, meaning it makes a successful bid mathematically impossible, or coercive, meaning it pressures shareholders into accepting or rejecting an offer without adequate information. Courts are skeptical of preclusive or coercive defenses and may enjoin them even if the board acted in good faith. For more detailed guidance on shareholder rights and hostile takeover defense strategy, see our practice area on shareholder rights and hostile takeover defense.
Boards should also evaluate whether the corporation's charter contains provisions that limit defensive tactics, such as a no-shop clause that restricts the board's ability to solicit competing bids. In the context of a hostile bid, the enforceability of such provisions depends on the bidder's status at the time the charter was adopted and the specific language used. Forward-looking strategic considerations include: documenting the board's evaluation of the bidder's offer and any alternative proposals in contemporaneous board minutes; ensuring that financial advisors provide written fairness opinions that explain the basis for their valuation; obtaining director and officer liability insurance that covers takeover-related claims; and establishing a clear communication protocol with shareholders that provides accurate, timely information about the board's position and the bidder's offer. These steps create a record that supports the board's fiduciary compliance and reduces exposure to shareholder derivative suits or appraisal actions that may arise after the transaction closes or is abandoned. For information on related risks such as account takeover fraud, which may accompany corporate control battles, boards should coordinate with internal audit and cybersecurity teams to ensure that bidders or hostile actors do not gain unauthorized access to sensitive corporate systems or financial accounts during the takeover process.
23 Apr, 2026
